Literature DB >> 23150970

Tofacitinib in active ulcerative colitis.

Stéphane Paul, Xavier Roblin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23150970     DOI： 10.1056/NEJMc1211073

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

Review 1.  Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?

Authors:  Mairi H McLean; Markus F Neurath; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

2.  A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.

Authors:  Taranjit S Gujral; Marina Chan; Leonid Peshkin; Peter K Sorger; Marc W Kirschner; Gavin MacBeath
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.